We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

172 hedge funds and large institutions have $542M invested in Meridian Bioscience Inc in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $262K | Put options by funds: $153K

16% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 51

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

1% more funds holding

Funds holding: 170 → 172 (+2)

8% less capital invested

Capital invested by funds: $592M → $542M (-$50M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
172
Holders Change
+2
Holders Change %
+1.18%
% of All Funds
4.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
59
Reduced
51
Closed
18
Calls
$262K
Puts
$153K
Net Calls
+$109K
Net Calls Change
-$144K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$5.65M
2
SCM
SG Capital Management
Illinois
+$5.23M
3
Morgan Stanley
Morgan Stanley
New York
+$4.12M
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.21M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.82M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$5.79M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$3.9M
4
BCM
Brown Capital Management
Maryland
-$2.24M
5
HEC
Hudson Executive Capital
New York
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
NCCM
126
Nine Chapters Capital Management
New Jersey
$166K +$10K +700 +6%
HIMCH
127
Hartford Investment Management Co (HIMCO)
Connecticut
$166K +$166K +11,600 New
JMPWA
128
JP Morgan Private Wealth Advisors
California
$163K +$1.17K +82 +0.7%
CCM
129
Catawba Capital Management
Virginia
$161K -$30K -2,100 -16%
PCM
130
Prelude Capital Management
New York
$160K +$20K +1,400 +14%
MSA
131
Mason Street Advisors
Wisconsin
$153K +$4.03K +282 +3%
PNC
132
Park National Corp
Ohio
$149K – – –
KeyBank National Association
133
KeyBank National Association
Ohio
$146K – – –
O
134
OppenheimerFunds
New York
$144K -$6.6K -462 -4%
CBB
135
Citizens Business Bank
California
$143K – – –
AG
136
Advisor Group
Arizona
$121K +$11.3K +794 +10%
SOADOR
137
State of Alaska Department of Revenue
Alaska
$119K +$1.14K +80 +1%
First Manhattan
138
First Manhattan
New York
$100K – – –
Nisa Investment Advisors
139
Nisa Investment Advisors
Missouri
$98K -$92.9K -6,500 -49%
PK
140
Pflug Koory
Nebraska
$83K -$11.1K -775 -12%
BC
141
Bartlett & Co
Ohio
$82K – – –
Barclays
142
Barclays
United Kingdom
$81K -$71.6K -5,009 -47%
PI
143
PineBridge Investments
New York
$75K -$4.62K -323 -6%
US Bancorp
144
US Bancorp
Minnesota
$63K – – –
TRCT
145
Tower Research Capital (TRC)
New York
$61K +$58.9K +4,125 +2,063%
Bank of Montreal
146
Bank of Montreal
Ontario, Canada
$53K -$123K -8,584 -70%
AIP
147
Ameritas Investment Partners
Nebraska
$49K – – –
CCMH
148
Cornerstone Capital Management Holdings
New York
$37K +$37.1K +2,600 New
RFM
149
Royal Fund Management
Florida
$32K – – –
IA
150
IFP Advisors
Florida
$30K +$214 +15 +0.7%
4 5
6
7 8

VIVO Hedge Fund Activity: Q3 2017 in Review

172 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2017, worth a combined $542M — down 8.5% from $592M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VIVO positions and 18 closed out — a net gain of 2 holders — while 59 added to existing stakes and 51 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.65M. The largest seller was UBS Group, cutting an estimated $6.82M.

  • 172 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2017, up from 170 in Q2 2017.
  • Funds reported $542M of Meridian Bioscience Inc stock for Q3 2017, down 8.5% quarter-over-quarter.
  • 20 funds opened new Meridian Bioscience Inc positions in Q3 2017 and 18 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2017 was Millennium Management, an estimated $5.65M added.
  • The largest Meridian Bioscience Inc seller in Q3 2017 was UBS Group, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2017.